watchdog – Health

AstraZeneca’s newly acquired Soliris is overpriced in myasthenia gravis, cost watchdog says

Now that Alexion’s Soliris is in AstraZeneca’s hands, the drugmaker is counting on the C5 inhibitor to help push it toward billions in sales in just a few years. But a prominent drug pricing watchdog is raising a red flag over its costs for patients with a rare neuromuscular disorder. The Institute for Clinical and… Read More »

Transparency watchdog criticizes STAT’s non-disclosure on pro-Pharma op-ed

Should publications that post op-ed pieces tell us more about who wrote the op-ed and what their potential biases and conflicts of interest might be? I’m in the camp that answers a resounding YES. Till Bruckner is, too. He writes for Transparify, an organization that rates “the financial transparency of major think tanks.” He is… Read More »